Multi-scale phylodynamic modelling of rapid punctuated pathogen evolution
Quang Dang Nguyen *, Sheryl L. Chang *, Carl J. E. Suster, Rebecca J. Rockett, Vitali Sintchenko, Tania C. Sorrell, Mikhail Prokopenko · 2024
Read Multi-scale phylodynamic modelling of rapid punctuated pathogen evolution by Quang Dang Nguyen *, Sheryl L. Chang *, Carl J. E. Suster, Rebecca J. Rockett, Vitali Sintchenko, Tania C. Sorrell, Mikhail Prokopenko (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2412-03896.txt.
Introduction
Quang Dang Nguyen and six co-authors build a pandemic model that links three scales at once, in a research paper from 2024. A pathogen evolves, sometimes in sudden jumps as new variants appear. People mix in varied populations. Public health rules then reshape behavior, feeding back on both spread and evolution.
Their framework couples an agent-based spread model with a model of pathogen evolution inside hosts. They test it on SARS-CoV-2 using global genome surveillance data. The combined model reproduces the main features of the COVID-19 pandemic and its variant waves. It also stays fast enough to run on large, mixed populations, which the authors stress is essential for real planning.
Catalog record
| CREATOR | Quang Dang Nguyen *, Sheryl L. Chang *, Carl J. E. Suster, Rebecca J. Rockett, Vitali Sintchenko, Tania C. Sorrell, Mikhail Prokopenko |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 127 KB |
| VERSION | 1.0 |
| LICENSE | http://creativecommons.org/licenses/by/4.0/ |
| RIGHTS | CC BY |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2412-03896
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Multi-scale phylodynamic modelling of rapid punctuated pathogen evolution Quang Dang Nguyen *, Sheryl L. Chang *, Carl J. E. Suster, Rebecca J. Rockett, Vitali Sintchenko, Tania C. Sorrell, Mikhail Prokopenko Abstract Computational multi-scale pandemic modelling remains a major and timely challenge. Here we identify specific requirements for a new class of models simulating pandemics across three scales: (1) pathogen evolution, often punctuated by the rapid emergence of new variants, (2) human interactions within a heterogeneous population, and (3) public health responses which constrain individual actions to control the disease transmission. We then present a pandemic modelling framework satisfying these requirements and capable of simulating feedback loops between dynamics unfolding at these different scales. The developed framework comprises a stochastic agent-based model of pandemic spread, coupled with a phylodynamic model that incorporates within-host pathogen evolution. It is validated with a case study, modelling the punctuated evolution of SARS-CoV-2, based on global and contemporary genomic surveillance data, which captures a large heterogeneous population. We demonstrate that the model replicates the essential features of the COVID-19 pandemic and virus evolution, while retaining computational tractability and scalability. August 24, 2026 K eywords agent-based model, phylodynamics, punctuated evolution, pandemic, complexity * : These authors contributed equally 1 Introduction Digital epidemiology is an emerging field, rapidly capitalising on the increasing availability of high-resolution genomic, immuno-epidemiological, demographic and human mobility data, social media analytics, high-performance computing power, as well as innovations in simulation methods and data science. In principle, these diverse sources of data should allow modellers to develop informative multi-scale pandemic models with a better capacity (i) to simulate realistic epidemiological, immunological and evolutionary dynamics, and (ii) to anticipate longer-term epidemiological and evolutionary dynamics as the pandemic unfolds. Yet, pandemic modelling continues to face significant challenges in concisely capturing relevant characteristics of pandemic pathogens, such as their pathogenesis, transmissibility, antigenicity, etc., as well as predicting long-term phylodynamic trajectories and future public health risks. These challenges arise due to (i) the inherent complexity of rapidly evolving pathogens, (ii) population heterogeneity (demographic, immunological and behavioural), and (iii) multi-objective public health interventions carried out under severe pressure and non-trivial social dynamics. The modelling complexity is exacerbated by (iv) different time scales needed to model pandemics on multiple levels, ranging from the range of evolutionary drivers and rates of the implicated pathogens to natural infections in individuals and their social behaviour and interactions, (v) fragmentation of data across heterogeneous sources, and (vi) computational complexity of multiple simulations over a sufficiently long horizon, required to examine the distribution of outcomes in many stochastic realisations of the model and across ranges of uncertainties in parameters such as substitution rate, fitness, accumulated mutations, and genomic diversity. Multi-scale models often suffer from the “curse of dimensionality”, when computational costs increase exponentially with the number of degrees of freedom [ 1 ] . A principal modelling problem is the presence of feedback loops: for example, pandemic mitigation measures may indirectly affect the pathogen evolution, leading to the emergence of more transmissible lineages. Higher transmissibility may increase the need for more vigorous interventions, which in turn may cause changes in how populations respond and behave, and constrain the pathogen evolution in a specific way. This feedback loop contributes to the formation of recurrent waves of infection, fluctuating genomic diversity, non-linear increases in fitness levels, and a potentially delayed transition to endemicity. Consequently, multi-scale modelling of a major pandemic crisis, such as COVID-19, quickly becomes intractable. Over the last decades, stochastic agent-based modelling (ABM) has been established as a robust tool for tracing fine-grained effects of complex intervention policies in diverse epidemic and pandemic settings [ 2 , 3 , 4 , 5 ] . Most recently, these studies produced policy recommendations developed for COVID-19 control, which were adopted in Australia [ 6 , 7 , 8 ] , the USA [ 9 ] , the UK [ 10 ] , and broadly by the WHO [ 11 ] . In these ABMs, each agent represents an individual human host with a set of demographic, epidemiological, and immunological attributes. A largely unexplored avenue to leverage the precision and fidelity of ABMs is to extend them with comprehensive phylodynamic modelling of evolving pathogens, going beyond existing phylogenetic models which define simplified evolutionary landscapes [ 12 , 13 ] . This necessitates a new class of multi-scale phylodynamic ABMs. An effective framework for multi-scale phylodynamic agent-based modelling should include the following distinct capabilities that produce quantifiable outcomes: Capability 1: Model and examine epidemic or pandemic patterns over a mid- to long-term timeframe, with respect to complex transmission and immunological profiles, affected by varying pharmaceutical and non-pharmaceutical interventions: (a) Reproduce and predict salient peaks and recurrent waves of incidence, prevalence, and other epidemic dynamics. (b) Explore possible transitions and pathways to endemicity or elimination. Capability 2: Examine the pathogen fitness with respect to its phylodynamics: (a) Trace changes in transmissibility with respect to pathogen mutations. This includes analysis of the average reproductive number within the population, and the accumulated mutations measured by the average genomic distance between a circulating genome and the ancestral genome, e.g., in terms of the nucleotide substitution rate. (b) Examine the functional dynamics (i.e., the relationship between the genome sequence and the pathogen’s epidemic behaviour). This analysis quantifies the individual contributions of amino acids to changes in the pathogen’s fitness, and traces the dynamics of these contributions to transmissibility and antigenicity over time. Capability 3: Detect and evaluate the emergence and dominance of variants of concern: (a) Explore concordance between phylodynamics and disease dynamics, e.g., relating accumulated mutations, genomic diversity, and saltations in pathogen fitness to incidence peaks. (b) Detect abrupt changes in genomic diversity, and evaluate emergence of variants of concern, by using appropriate quantitative techniques (such as Augmented Dickey-Fuller stationarity test, CUSUM, etc.), supported by suitable data visualisation methods (such as phylogenetic trees). A robust phylodynamic ABM needs to be validated by comparing its target outcomes against the ground truth dynamics. Once validated, it can be used to explore diverse counterfactual scenarios with respect to phylodynamic, demographic and immuno-epidemiological characteristics. We illustrate the ground truth dynamics, matching the three capabilities, in Figs 1 to 4 , by using available genomic and disease surveillance data on SARS-CoV-2 and COVID-19 respectively from 2020 to 2024 (we note that the detected incidence is affected by the testing capacity). To demonstrate Capability 1 , a modelling framework is expected to generate pandemic or epidemic patterns aligned with ground truth (i.e., observed data). For example, Fig 1 shows patterns observed in global data reported during the COVID-19 pandemic, highlighting prominent peaks and recurrent incidence waves. We point out that each incidence peak is temporally aligned with the emergence of a new variant of concern. Notably, the two most prominent incidence peaks occurred in early 2022 and early 2023, corresponding to the dominance of Omicron BA.1 and Omicron XBB, respectively. These observations suggest a complex interplay between pandemic patterns and evolutionary phylodynamic features of the viral variants in circulation. Figure 1: Capability 1. Pandemic patterns in terms of the worldwide incidence (solid, black line), measured as new weekly cases per million [ 14 ] , overlaid with the frequency of circulating variants between 2020 and 2024, plotted using open SARS-CoV-2